Full Answer
How do I contact Sun Pharma products?
Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients in more than 100 countries worldwide. If you have any questions about Sun Pharma Products, please contact Sun Pharma Customer Service at 800-818-4555.
Will Sunsun Pharma share my information with anyone else?
Sun Pharma will not share your information with anyone else except as required by law. By using the ILUMYA ® Copay Card or participating in the Early Access Program, or both, you attest that you meet the eligibility criteria and will comply with the Terms and Conditions.
What is the role of Science at Sun Pharma?
Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas. Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.
See more
Is Sun Pharma a reputable company?
Sun Pharmaceutical Industries is rated 4.1 out of 5, based on 4.0k reviews by employees on AmbitionBox. Sun Pharmaceutical Industries is known for Skill development which is rated at the top and given a rating of 4.1. However, Work-Life balance is rated the lowest at 3.8 and can be improved.
What drugs does Sun Pharma make?
Over-the-Counter Medications There are other category defining brands such as Coldact & Flustat (cold & flu), Brustan, Painamol & Paduden (analgesics), Aspenter, Aspacardin, Nudrate & Fortifikat (lifestyle OTCs), Gestid (digestives) and Chericof (cough).
Why did Sun Pharma fall?
The loss came on account of settlement charges of pending litigations in the US, and restructuring operations in some countries. Adjusted profit grew 18 per cent year on year (YoY) to Rs 1,582 crore. Consolidated sales from operations rose 11 per cent YoY at Rs 9,386 crore over Q4 last year.
Is Sun Pharma listed in US?
In the United States, the company markets a large basket of generics, with a strong pipeline awaiting approval from the U.S. Food and Drug Administration (FDA). Sun Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times.
What is the rank of Sun Pharma in world?
fourth largest(Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US$ 4.5 billion.
Who is owner of Sun Pharma?
Dilip ShanghviDilip Shanghvi is the founder of Sun Pharmaceutical Industries Ltd. and has extensive industrial experience in the pharmaceutical industry.
Which is the No 1 pharma company in India?
Sun Pharmaceutical industriesOn the top of the list is Sun Pharmaceutical industries with a market cap standing at Rs 1,63,875 crore. As regards the company, Sun Pharmaceuticals is the largest pharmaceutical company from India and the fifth largest specialty generic company in the world.
What is the future of Sun Pharma?
The higher strength in a market that normally grows at 10 per cent, is expected to translate into even higher growth for Sun Pharma which focusses on product launches (28 launched in Q2FY22 alone) and in-licensing opportunities. Sun Pharma reported sales growth of 2.5 per cent in FY21 of ₹33,139 crore.
What happened to Sun Pharma?
Shares of Sun Pharmaceutical Industries plunged by over 4% in Tuesday's deals to ₹851 apiece on the BSE the drug firm's consolidated net loss stood at ₹2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
What is the salary of CEO of Sun Pharma?
Dilip Shanghvi, promoter and Managing Director of Sun Pharmaceutical Industries (Sun Pharma), forewent 99 percent of his FY19 salary as India's largest drug maker optimised operational costs due to pricing pressure and moderating growth in US. Shanghvi took home Re 1 as salary in FY19 from around Rs 3 crore in FY18.
Is Sun Pharma Debt Free?
The company has repaid debt of about $209 million in the first half of FY22 compared with the debt as of March 31, 2021. With this debt repayment, Sun Pharma had a net cash of about $200 million as of September 30, 2021, on ex-Taro basis.
Is Sun Pharma FDA approved?
(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) today announced that it has received approval from the U.S. Food and Drug Administration (USFDA) for INFUGEM™ (gemcitabine in 0.9% sodium chloride injection) 10 mg/mL, for intravenous ...
Is Sun Pharma FDA approved?
(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) today announced that it has received approval from the U.S. Food and Drug Administration (USFDA) for INFUGEM™ (gemcitabine in 0.9% sodium chloride injection) 10 mg/mL, for intravenous ...
How many divisions does Sun Pharma have?
six operating divisionsFollowing the TND purchase, Sun reorganized its operations, regrouping its businesses into six operating divisions.
How many subsidiaries does Sun Pharma have?
URL as a group includes five wholly-owned subsidiaries, AR Scientific, Inc., Mutual Pharmaceutical Company, Inc., United Research Laboratories, Inc., Dungan Mutual Associates, LLC, and URL PharmPro, LLC.
What is the net worth of Dilip Shanghvi?
14.9 billion USD (2022)Dilip Shanghvi / Net worth
What is Sun Pharma?
Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.
What is the vision of GXP?
Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.
What is Taro dermatologicals?
It is a leading manufacturer and supplier of topical dermatologicals with a growing line of both, topical products and solid dosage formulations mainly used in cardiology and neurology therapies.
What is a DUSA?
DUSA is focused on the development and marketing of dermatology products. DUSA’s flagship product, Levulan® photodynamic therapy (PDT), is a technology platform used in conjunction with its proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator, for the treatment of minimally to moderately thick Actinic Keratosis of the face or scalp.
Is Sun Pharma a US company?
Sun Pharma is present in the US through its own legal entities as well as its subsidiary, Taro Pharmaceuticals. Over the last few years, Sun Pharma has made several acquisitions in the US, including Caraco, DUSA Pharmaceuticals and Pharmalucence.
What information do you need to activate a Copay card?
Before you activate your Copay Card or participate in the Early Access Program, it is important that you understand that you will be asked to provide personal information that may include your name, address, phone number, email address, and information related to your prescription medication insurance and treatment.
Does Sun Pharma share your information?
Sun Pharma will not share your information with anyone else except as required by law. By using the ILUMYA ® Copay Card or participating in the Early Access Program, or both, you attest that you meet the eligibility criteria and will comply with the Terms and Conditions.
Is Ilumya a health insurance?
These offers are not health insurance and are only valid for patients in the United States, Guam, Virgin Islands, or Puerto Rico. The Early Access Program provides ILUMYA ® at no charge to patients for up to 2 years or until they receive insurance coverage approval, whichever occurs earlier.
